Study to Document Treatment Patterns and to Evaluate Leuprolide and Alternative Therapeutic Approaches to the Treatments of Advanced Prostate Cancer

NCT01081873 · clinicaltrials.gov ↗

COMPLETED

Status

2717

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostatic Neoplasm

Interventions

DRUG: leuprolide (Lucrin/Lucrin-Tri-depot)

Sponsor

Abbott